MESA LABORATORIES INC MLAB 68.02
Technology · NASDAQ · Data as of 2026-08-10
MESA LABORATORIES INC (MLAB) has delivered +13.7% annualized revenue growth, n/a earnings growth, and +5.3% dividend growth over 10 years of data. Ranked #317 of 1968 stocks overall and #39 of 362 in the Technology sector by Steady Score.
About MESA LABORATORIES INC
Company Overview
Mesa Laboratories develops instruments and consumables used to verify quality and safety in regulated processes. Its products monitor sterilization, calibrate equipment, measure critical parameters and support biopharmaceutical development. Pharmaceutical producers, medical-device manufacturers, hospitals, laboratories and food processors use Mesa tools to document that processes and equipment perform within required limits.
Read more
Business Model & Revenue
Revenue comes from instruments, recurring indicators and consumables, calibration and maintenance services, and software. Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development and Calibration Solutions serve separate workflows. Installed equipment and routine validation create repeat demand. Regulatory production volumes, laboratory budgets, service contracts and acquisitions drive sales, while quality systems and specialized manufacturing shape costs.
Key Facts & Market Position
Mesa focuses on measurement and validation steps that customers must perform even though the products are a small part of overall production cost. Regulatory documentation and consistent performance support sticky workflows. The company has grown through acquisitions, making integration and debt management important alongside technical accuracy, supply reliability and compliance.